D61.0 Constitutional aplastic anemia

Name of the Condition

• Constitutional aplastic anemia (ICD-10 Code D61.0)

Summary

Constitutional aplastic anemia is a rare inherited disorder characterized by bone marrow failure, leading to insufficient production of blood cells. This condition results in anemia, increased susceptibility to infections, and bleeding tendencies due to low red blood cell, white blood cell, and platelet counts. It is typically present from birth or early childhood and may be associated with other congenital anomalies.

Causes

The condition is caused by genetic mutations that affect bone marrow function, often inherited in an autosomal recessive pattern. These mutations disrupt the development or function of hematopoietic stem cells, impairing blood cell production. In some cases, the specific genetic defect may involve DNA repair mechanisms or telomere maintenance.

Risk Factors

• Family history of constitutional aplastic anemia or related bone marrow disorders.
• Consanguinity (parents who are closely related) increases the likelihood of inheriting recessive genetic mutations.
• Presence of other congenital anomalies or syndromes associated with bone marrow failure.

Symptoms

• Persistent fatigue and weakness due to anemia.
• Frequent or severe infections from low white blood cell counts.
• Easy bruising, nosebleeds, or prolonged bleeding from minor injuries due to thrombocytopenia.
• Pale skin, shortness of breath, or dizziness, particularly with exertion.
• In some cases, physical abnormalities may be present, depending on associated syndromes.

Diagnosis

Diagnosis involves blood tests showing pancytopenia (low counts of all major blood cell types) and a bone marrow biopsy revealing hypocellular marrow with reduced hematopoietic cells. Genetic testing may identify specific mutations. Additional evaluations assess for associated congenital anomalies or syndromes.

Treatment Options

• Supportive care, including blood transfusions and antibiotics for infections.
• Hematopoietic stem cell transplantation, which may be curative if a suitable donor is available.
• Growth factors or immunosuppressive therapy in select cases, though effectiveness varies.
• Management of associated complications, such as bleeding or organ dysfunction.

Prognosis and Follow-Up

Prognosis depends on the severity of bone marrow failure and response to treatment. Early intervention, particularly stem cell transplantation, improves outcomes. Long-term follow-up is essential to monitor for relapse, secondary malignancies, or treatment-related complications. Genetic counseling is recommended for families.

Complications

• Severe infections due to neutropenia.
• Life-threatening bleeding from thrombocytopenia.
• Iron overload from repeated transfusions.
• Development of myelodysplastic syndromes or leukemia in some cases.
• Organ damage from chronic anemia or hypoxia.

Lifestyle & Prevention

• Avoid exposure to toxins, radiation, or medications that may worsen bone marrow function.
• Practice good hygiene to reduce infection risk.
• Follow dietary recommendations to support overall health and manage anemia.
• Genetic counseling for families planning future pregnancies.

When to Seek Professional Help

Seek immediate medical attention for:

• Unexplained or worsening fatigue, weakness, or shortness of breath.
• Frequent or severe infections.
• Unusual bruising, bleeding, or prolonged bleeding from minor injuries.
• Signs of organ dysfunction, such as jaundice or swelling.

Tips for Medical Coders

• Code D61.0 is specific to constitutional aplastic anemia, distinct from acquired forms. Ensure documentation confirms congenital or inherited etiology.
• Verify if associated congenital anomalies or syndromes are documented, as these may require additional coding.
• Confirm that bone marrow failure is not secondary to other conditions (e.g., chemotherapy, toxins) to avoid miscoding.
• Document genetic testing results or family history when available to support the diagnosis.